Drug Shortage Report for LUSTRA-AF
| Report ID | 2113 |
| Drug Identification Number | 02242934 |
| Brand name | LUSTRA-AF |
| Common or Proper name | Lustra-AF |
| Company Name | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | OCTINOXATE HYDROQUINONE AVOBENZONE |
| Strength(s) | 7.5% 4% 3% |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL |
| Packaging size | 28.4 g |
| ATC code | D11AX |
| ATC description | OTHER DERMATOLOGICAL PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2015-01-01 |
| Actual start date | 2015-01-01 |
| Estimated end date | Unknown |
| Actual end date | 2015-06-30 |
| Shortage status | Resolved |
| Updated date | 2019-08-19 |
| Company comments | Discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-08-19 | French | Compare |
| v3 | 2019-08-19 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 4 of 4